AVIR - Atea Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts4433
Avg. Estimate-0.47-0.53-2.13-2.84
Low estimate-0.55-0.7-2.57-3.5
High estimate-0.42-0.47-1.87-2.21
Year ago EPS-0.38-0.1-1.39-2.13
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts3343
Avg. EstimateN/AN/AN/A28.81M
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/A86.44M
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-0.52-0.44-0.45-0.48
Actual EPS-0.38-0.1-0.41-0.43
Difference0.140.340.040.05
Surprise %26.90%77.30%8.90%10.40%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.47-0.53-2.13-2.84
7 days ago-0.47-0.53-2.13-2.84
30 days ago-0.45-0.48-2.02-2.56
60 days ago-0.49-0.52-2.22-2.81
90 days ago-0.57-0.62-2.67-1.61
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days2121
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesAVIRIndustrySector(s)S&P 500
Current qtr.-23.70%N/AN/AN/A
Next qtr.-430.00%N/AN/AN/A
Current year-53.20%N/AN/AN/A
Next year-33.30%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A